Onatasertib
Onatasertib (CC223) is a potent and selective oral mTOR kinase inhibitor with an IC50 of 16 nM, showing over 150-fold selectivity against PI3Kα. It suppresses tumor cell proliferation and induces apoptosis, demonstrating antitumor activity in preclinical in vitro and in vivo cancer models.
Product Specifications
CAS Number
1228013-30-6
Product Name Alternative
MTOR, inhibit, Onatasertib, FLT4, Inhibitor, Mammalian target of Rapamycin, DNAPK, DNA-PK, CC223, CC-223, CC 223, Apoptosis, ATG 008, ATG008, ATG-008, cFms, c-Fms, PI3K-α
Field of Research
Cardiovascular Research, Cell Biology, Molecular Biology, Signal Transduction
Purity
99.14% (May vary between batches)
Solubility
DMSO:70 mg/mL (176.11 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.03 mM) ; Ethanol:73 mg/mL (183.66 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
CO[C@H]1CC[C@@H] (CC1) N1C (=O) CNc2ncc (nc12) -c1ccc (nc1) C (C) (C) O
Molecular Formula
C21H27N5O3
Molecular Weight
397.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
